Archive · 24 Sep 2025
HVAX Technologies Eyes Expansion with ₹313 Crore Order Book
HVAX Technologies, a company that builds infrastructure for biotech, hospitals and pharma, has a lot of work lined up.
They currently have orders worth ₹313 crore.
They are also looking at projects that could be worth ₹682 crore, thanks to new investments.
HVAX is planning to grow, especially in the hospital sector in India.
They are also looking to expand in areas like the Middle East, Asia, and Latin America.
They are talking with other companies to help them expand.
The company also showed a positive financial performance, with its shares up by 6%.
HVAX Technologies is a turnkey pharmaceutical project integrator.
The company's current order book is valued at ₹313 crore.
HVAX is targeting projects worth ₹682 crore.
The company plans expansion in the GCC, Asia-Pacific, and LATAM regions.
HVAX is evaluating opportunities in the semiconductor and solar industries.
- Who
- HVAX Technologies
- What
- Plans expansion and has an order book of ₹313 crore.
- When
- As of September-end, Published on September 24, 2025.
- Where
- Over 15 countries, with focus on GCC, Asia-Pacific and LATAM regions.
- Why
- To address growing needs in India's hospital services market and explore opportunities in other industries.
- Order Book
- ₹313 crore
- Potential Project Value
- ₹682 crore
- Company Focus
- Turnkey pharmaceutical project integrator
- Areas of Operation
- Biotech, hospitals, pharmaceutical facilities
- Geographic Expansion
- GCC, Asia-Pacific, LATAM
- Share Price Increase
- 6% (₹995)